Internal Medicine Alert (Vol. 38, No. 11) - June 15, 2016

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: June 2016

Valid through: June 2019

Target Audience

This CME activity is intended for the internist/family physician.

Subjects

  • Welcome Back, Saturated Fat
  • The Efficacy of Spironolactone for the Treatment of Drug-resistant Hypertension
  • Fitness and Cognition in the Elderly
  • Pharmacology Update: Pimavanserin Tablets (Nuplazid)
  • Clinical Briefs: Glucose Variability in T2DM: Ready for Prime Time?; Improvements in Pain and Physical Function After Bariatric Surgery; Two Thumbs Down for COPD Screening
  • ECG Review: Why is This Young Athlete’s ECG Abnormal?

Objectives

  • Describe new findings in differential diagnosis and treatment of various diseases;
  • Describe the advantages, disadvantages, and controversies surrounding the latest advances in the diagnosis and treatment of disease;
  • Identify cost-effective treatment regimens;
  • Explain the advantages and disadvantages of new disease screening procedures.

Credit Available

Physicians

  • Maximum of 2.0 AMA PRA Category 1 Credits
  • 2.0 AOA Category 2-B credits
  • 1.0 AAFP Credits

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Osteopathic Association has approved this continuing education activity for up to 2.0 AOA Category 2-B credits.

Internal Medicine Alert has been reviewed and is acceptable for up to 1.0 Prescribed credit by the American Academy of Family Physicians. AAFP accreditation begins Jan. 1, 2016. Term of approval is for one year from this date with the option of yearly renewal.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Faculty Listing

Authors

EDITOR

Stephen A. Brunton, MD

Adjunct Professor of Pharmacy Practice

College of Pharmacy

Roseman University of Health Sciences

Salt Lake City 

 

ASSOCIATE EDITORS

James Chan, PharmD, PhD

Pharmacy Quality and Outcomes Manager

Kaiser Permanente

Oakland, CA

 

William T. Elliott, MD, FACP

Chair, Formulary Committee

Northern California Kaiser Permanente

Assistant Clinical Professor of Medicine
University of California, San Francisco

 

Ken Grauer, MD

Professor Emeritus in Family Medicine

College of Medicine

University of Florida

 

William C. Haas III, MD, MBA

Integrative Medicine Fellow

Department of Family and Community Medicine

University of Arizona

 

Harold L. Karpman, MD, FACC, FACP

Clinical Professor of Medicine

David Geffen School of Medicine

UCLA

Cardiovascular Medical Group

 

Louis Kuritzky, MD

Clinical Assistant Professor

University of Florida

 

Joseph E. Scherger, MD, MPH

Vice President, Primary Care

Eisenhower Medical Center

Clinical Professor

Keck School of Medicine

University of Southern California

 

PEER REVIEWER

Gerald Roberts, MD

Senior Attending Physician Long Island Jewish Medical Center NS/LIJ Health Care System

New Hyde Park, NY

 

Financial Disclosure

Internal Medicine Alert’s Editor Stephen Brunton, MD, is a retained consultant for Abbott, Actavis, AstraZeneca, Becton Dickinson, Boehringer Ingelheim, Cempra, Exact Sciences, Janssen, Lilly, Mylan, Novo Nordisk, and Teva; he serves on the speakers bureau of AstraZeneca, Boehringer Ingelheim, Janssen, Lilly, Novo Nordisk, and Teva. Contributing Editor Louis Kuritzky is a retained consultant for AbbVie, Allergan, AstraZeneca, Janssen, Lilly, Lundbeck, Medscape, Novo Nordisk, and Sanofi Aventis; he serves on the speakers bureau of Lilly and Lundbeck. Peer Reviewer Gerald Roberts, MD; Executive Editor Leslie Coplin; and Associate Managing Editor Jonathan Springston report no financial relationships relevant to this field of study.

 

Drs. Elliott, Chan, Haas, Karpman, and Scherger report no financial relationships relevant to this field of study.

 

Dr. Grauer is the sole proprietor of KG-EKG Press, and publisher of an ECG pocket brain book.

 

Copyright 2016, AHC Media. All rights reserved.